| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214553 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 33 Pages |
Abstract
TomoTherapy appeared to be more expensive than RapidArc mainly due to the higher price of the accelerator, the higher costs of maintenance, and the longer duration of treatment sessions. Because strategies were not significantly different in clinical effect, RapidArc appeared to be the strategy to be recommended at this stage of knowledge.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Lionel PhD, HDR, Magali MSc, Pascal MD, PhD, Pierre MD, Bernard MD, Olivier MD, Marc MD, Etienne MD, Michel MD, Valentin MD, PhD, Enrique MD, Georges MD, PhD, Hinda MD, David MD, Sophie MD, Philippe MD, PhD,